UNIGE document Scientific Article
previous document  unige:21156  next document
add to browser collection

High prevalence of severe vitamin D deficiency in combined antiretroviral therapy-naive and successfully treated Swiss HIV patients

Mueller, Nicolas J.
Fux, Christoph A.
Ledergerber, Bruno
Elzi, Luigia
Dang, Thanh
Magenta, Lorenzo
show hidden authors show all authors [1 - 10]
Published in AIDS. 2010, vol. 24, no. 8, p. 1127-1134
Abstract OBJECTIVES: To evaluate the prevalence of 25-hydroxyvitamin D [25(OH)D] deficiency in HIV-positive patients, a population at risk for osteoporosis. DESIGN: Retrospective assessment of vitamin D levels by season and initiation of combined antiretroviral therapy (cART). METHODS: 25(OH)D was measured in 211 HIV-positive patients: samples were taken before initiation of cART from February to April or from August to October as well as 12 (same season) and 18 months (alternate season) after starting cART. 1,25-Dihydroxyvitamin D [1,25(OH)2D] was measured in a subset of 74 patients. Multivariable analyses included season, sex, age, ethnicity, BMI, intravenous drug use (IDU), renal function, time since HIV diagnosis, previous AIDS, CD4 cell count and cART, in particular nonnucleoside reverse transcriptase inhibitor (NNRTI) and tenofovir (TDF) use. RESULTS: At baseline, median 25(OH)D levels were 37 (interquartile range 20-49) nmol/l in spring and 57 (39-74) nmol/l in the fall; 25(OH)D deficiency less than 30 nmol/l was more prevalent in spring (42%) than in fall (14%), but remained unchanged regardless of cART exposure. In multivariable analysis, 25(OH)D levels were higher in white patients and those with a longer time since HIV diagnosis and lower in springtime measurements and in those with active IDU and NNRTI use. 1-Hydroxylation rates were significantly higher in patients with low 25(OH)D. Hepatitis C seropositivity, previous AIDS and higher CD4 cell counts correlated with lower 1,25(OH)2D levels, whereas BMI and TDF use were associated with higher levels. In TDF-treated patients, higher 1,25(OH)2D correlated with increases in serum alkaline phosphatase. CONCLUSION: Based on the high rate of vitamin D deficiency in HIV-positive patients, systematic screening with consideration of seasonality is warranted. The impact of NNRTIs on 25(OH)D and TDF on 1,25(OH)2D needs further attention.
Keywords AdultAlkaline Phosphatase/*blood*Antiretroviral Therapy, Highly ActiveComorbidityFemaleHIV Infections/*complications/drug therapy/epidemiology*Hiv-1HumansMaleMiddle AgedOsteoporosis/*blood/epidemiologyPrevalenceRetrospective StudiesRisk AssessmentRisk FactorsSwitzerland/epidemiologyVitamin D/*blood/therapeutic useVitamin D Deficiency/blood/complications/drug therapy/epidemiology/*etiology
PMID: 20168200
Full text
Article - document accessible for UNIGE members only Limited access to UNIGE
Research group Unité HIV (46)
(ISO format)
MUELLER, Nicolas J. et al. High prevalence of severe vitamin D deficiency in combined antiretroviral therapy-naive and successfully treated Swiss HIV patients. In: AIDS, 2010, vol. 24, n° 8, p. 1127-1134. doi: 10.1097/QAD.0b013e328337b161 https://archive-ouverte.unige.ch/unige:21156

428 hits



Deposited on : 2012-05-23

Export document
Format :
Citation style :